Debu Tripathy, M.D.

Developmental Pathways: A Key to Effective Treatments for Lymphoid Malignancies

March 18, 2023

Personalized medicine means not only more powerful drugs for cancers, but also more precise mechanisms that target the specific consequence of mutations and other alterations that drive cancer cell growth, sparing normal cells.

Targeting Lung Cancer From a New Direction

November 23, 2021

It is my hope that the cancer field continues to grow the novel therapy for not only patients with lung cancer, but well beyond. It is critical that the public be aware of how research and clinical trials are catalysts to better the outcomes of patients with cancer.

Cancer Researchers Are Expanding Options for Brain Metastases

October 14, 2021

Brain metastases are a pattern of spread we are seeing more for many tumor types as patients are living longer with metastatic cancer and we more readily use an array of brain imaging technologies when needed.

Balancing Cancer Screenings and COVID-19 Safety

March 25, 2021

Although COVID-19 has shaken our lives in so many ways, it’s important to keep our health one of our top priorities while also staying safe. We must find widely acceptable ways to screen for cancer in this new era so that we don’t turn the clock back on the gains we have made in the past few decades.

Closer to a Cure for Mantle Cell Lymphoma

September 25, 2020

Mantle Cell Lymphoma (MCL), as described in this issue of CURE®, has an interesting and inspiring story. It was one of the first cancers known to have a genetic abnormality-chromosomal translocation t(11;14).